NovoMedix Presents New Preclinical Data on NMX2 at the 2022 American Heart Association (AHA) Scientific Sessions Meeting
SAN DIEGO, Nov. 7, 2022 /PRNewswire/ -- NovoMedix, ...
NovoMedix Receives Research Grant from the National Institutes of Health (NIH) to Advance NMX1 in TNBC
NovoMedix, LLC ("NovoMedix"), a biotechnology ...
A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure
Cardiac fibroblasts are critical mediators ...